COPENHAGEN, Denmark – Novonesis has reported robust sales momentum, largely driven by its bioenergy business including ethanol and biodiesel solutions, underscoring the company’s expanding footprint in renewable fuel markets.
In the third quarter of 2024, Novonesis recorded approximately 11% organic sales growth across the group, with the “Agriculture, Energy & Tech” segment posting around 12% growth. Within that, the “Energy” sub‑segment — covering ethanol and biodiesel solutions — drove much of the growth. The company cited increased production of ethanol especially in Latin America and India, as well as strong uptake of biodiesel solutions globally. For the first nine months of 2025, Novonesis reported 8% organic sales growth, and lifted its full‑year organic sales growth outlook to 7‑8% (previously 6‑8%).
In Q3 2025, net sales reached approximately €1.065 billion, up from €1.020 billion a year ago; adjusted earnings also rose (to €192.1 million from €161.3 million).
Novonesis’ bioenergy growth is strongly linked to global renewable‑fuel trends:
Ethanol production capacity is expanding in Latin America and India, where Novonesis’ solutions are gaining traction.
In North America, ethanol output and adoption of innovative enzyme/yeast technologies are supporting upstream growth. Biodiesel solutions also contributed meaningfully — the company points to “strong development in biodiesel solutions” across geographies.
The company reiterated its ambition towards 2030, with investments in sustainable biosolutions underpinning its growth thesis.
While overall growth is solid, management indicated that Q4 may be more moderate, expecting “mid‑single‑digit” organic growth in that quarter.
The resilience in the energy segment helps diversify Novonesis away from purely food/health‑facing biosolutions toward higher‑growth sustainable fuel markets.
Novonesis’ strong Q3 growth is a signal that the renewable‑fuel sector (especially ethanol and biodiesel) is becoming a more meaningful component of its portfolio. For investors and market watchers, this suggests: A structural tailwind in bioenergy demand (driven by global decarbonisation & fuel‑mandates)
A competitive edge for Novonesis in enzyme / microbial / bioprocessing technologies for fuel production Continued importance of emerging markets (Latin America, India) in driving volume and capacity expansion.
